The bilateral sentinel node detection rate of fluorescent indocyanine green compared to 99mTc and blue dye inthe sentinel node procedure in stage I-IIA cervical cancer
Key facts
- Where
- Utrecht, HollandiaSee the site
- Phase
- 4. fázis
Where in Hollandia
- Universitair Medisch Centrum UtrechtUtrecht, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Medisch Centrum Utrecht
- Trial code
- EU 2024-511966-36-00
- Record updated
- 2024. május 10.
- Original description
To evaluate the bilateral SLN detection rate of intraoperative ICG with NIR fluorescence imaging compared to the current standard of care of 99mTc (with preoperative SPECT/CT) and blue dye.Read full original descriptionShow less
The bilateral sentinel node detection rate of fluorescent indocyanine green compared to 99mTc and blue dye in the sentinel node procedure in stage I-IIA cervical cancer
To evaluate the bilateral SLN detection rate of intraoperative ICG with NIR fluorescence imaging compared to the current standard of care of 99mTc (with preoperative SPECT/CT) and blue dye.
Inclusion: Age ≥18 years and able to provide informed consent; - A histopathologically proven primary malignancy of the cervix uteri; - FIGO stage IA1-IB2 or IIA1 (according to the FIGO 2018 guidelines39); - Radical surgery is planned including a SLN procedure.
Exclusion: Pregnancy or current breastfeeding (confirmation by a pregnancy test is the current standard of care) - Renal insufficiency stage 3 or 4. - Prior allergic reaction to ICG, 99mTc or patent blue. - Prior severe allergic reaction to iodine.